SPRO - Spero Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

SPRO is currently covered by 2 analysts with an average price target of $6. This is a potential upside of $5.26 (710.81%) from yesterday's end of day stock price of $0.74.

Spero Therapeutics's activity chart (see below) currently has 45 price targets and 46 ratings on display. The stock rating distribution of SPRO is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 12.96% of the time, taking 40.67 days on average.

Highest price target for SPRO is $6, Lowest price target is $6, average price target is $6.

Most recent stock forecast was given by JOSHUA SCHIMMER from EVERCORE on 28-Oct-2026.

Currently out of the existing stock ratings of SPRO, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 28-Oct-2026

$6

$4.97 (482.52%)

$8

23 days ago
(28-Oct-2026)

0/4 (0%)

$4.83 (412.82%)

Buy Since 04-Sep-2019

$6

$4.97 (482.52%)

2 months 6 days ago
(14-Sep-2026)

0/17 (0%)

$4.86 (426.32%)

Buy Since 08-Feb-2018

2 years 5 days ago
(15-Nov-2024)

0/5 (0%)

$3.35 (203.03%)

Buy Since 20-May-2022

$2

$31

4 years 6 months ago
(20-May-2022)

1/2 (50%)

$0.62 (44.93%)

125

Buy Since 02-Oct-2019

$20

5 years 1 months 19 days ago
(01-Oct-2021)

2/3 (66.67%)

$3.26 (19.47%)

241

Show more analysts

Please expand the browser size to see the chart

What is SPRO (Spero Therapeutics) average time for price targets to be met?

On average it took 41 days for the stock forecasts to be reached, with an average price target met ratio of 12.96%.

Which analyst most recently updated their price target on SPRO (Spero Therapeutics)?

Josh Schimmer

Which analyst has the most public recommendations on SPRO (Spero Therapeutics)?

Josh Schimmer works at CANTOR FITZGERALD and has 3 price targets and 3 ratings on SPRO

Which analyst is the currently most bullish on SPRO (Spero Therapeutics)?

Ed Arce with the highest potential upside of $25.97

Which analyst is the currently most reserved on SPRO (Spero Therapeutics)?

Raghuram Selvaraju with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?